Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Pandoraon Dec 03, 2021 2:31pm
455 Views
Post# 34196101

RE:RE:RE:RE:RE:RE:RE:Warrants January 2021 to January 2023

RE:RE:RE:RE:RE:RE:RE:Warrants January 2021 to January 2023Thanks menoalittle -- I have posted that 'expired' info about the 37.5 cent warrants at least 2 maybe 3 times but it appears many don't read my notes. I now kind of wish they had not expired but they did.


menoalittle wrote: >> According to the latest finial report there are 72.473 million warrants 
>> outstanding as follows:
>> 4.6 M @ 0.375 expiring Jan 2022

What baloney.  Don't know why you're posting such crappy info (maybe you're just ignorant), but just to clear up any confusion that may have resulted from it, the following is clipped straight from the Q3 financial report (item 20), and from the MD&A (pg 19):
_______________________________________

20. Subsequent Events
On November 10, 2021, warrants totaling 4,555,266 expired unexercised.

_______________________________________

As of November 29, 2021, there were 67,918,665 warrants outstanding. Each whole warrant entitles the holder thereof to purchase one additional common share. The warrants are exercisable as follows: 3,165,009 at a price of $0.50 until October 3, 2022, 4,095,157 at a price of $0.50 until January 9, 2023, 3,159,000 at a price of $0.30 until May 14, 2022 and 57,499,000 at a price of $0.35 until August 22, 2024.


<< Previous
Bullboard Posts
Next >>